This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Gunze Limited, Kyoto University. Active years: 1992-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-2020
Title: Shigehiko Suzuki: Innovator in Therapeutic Solutions
Introduction
Shigehiko Suzuki is a prominent inventor based in Kyoto, Japan, known for his contributions to medical innovations. With a total of three patents, his work focuses on developing advanced therapeutic compositions and substrates for tissue regeneration.
Latest Patents
Among his latest patents, Suzuki has developed a therapeutic or prophylactic composition for TDP-43 proteinopathy. This invention targets the TDP-43 gene using microRNA, aiming to provide effective treatments for neurological conditions associated with TDP-43 pathology. His other notable patent involves a tissue regeneration substrate that releases basic fibroblast growth factors (bFGF) in a sustained manner. This formulation, which incorporates collagen and gelatin, is designed to enhance tissue regeneration by facilitating cellular entry.
Career Highlights
Shigehiko Suzuki has had a fruitful career, working with renowned organizations such as Gunze Limited and Kyoto University. His career reflects a commitment to pioneering research and development in the biomedical field, making a significant impact on therapeutic methodologies.
Collaborations
Throughout his career, Suzuki has collaborated with notable professionals, including Shinichiro Morita and Nobuya Takahashi. These partnerships have contributed to the success and advancement of his innovative projects.
Conclusion
In conclusion, Shigehiko Suzuki's inventions, particularly in targeting TDP-43 proteinopathy and tissue regeneration, represent significant advancements in medical science. His work continues to inspire fellow inventors and researchers in the quest for groundbreaking solutions in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile